Acute Versus Chronic GVHD
Last Updated: Monday, November 29, 2021
Two experts in the field of graft-versus-host disease—Diya Sabnani, APRN, AGACNP-BC, and Jaime Shahan, MPAS, PA-C, both of University of Texas Southwestern—discuss the differences between acute and chronic GVHD, including the various organ systems involved and the importance of closely monitoring patients.
Meet the faculty
Diya Sabnani
APRN, AGACNP-BC
University of Texas Southwestern Medical Center
Diya Sabnani, APRN, AGACNP-BC, is a nurse practitioner on the Inpatient Bone Marrow Transplant team at UTSWMC. She worked at the bedside doing bone marrow transplant as a transplant nurse for seven years, before becoming an NP. She has experience with both acute and chronic GVHD, and she now works primarily in the inpatient setting.
Jaime Shahan
MPAS, PA-C
University of Texas Southwestern Medical Center
Jaime Shahan, MPAS, PA-C, is a physician assistant in the Bone Marrow Transplant and Hematologic Malignancies Clinic in the Harold C. Simmons Comprehensive Cancer Center at UTSWMC. She works closely with not only patients who have just completed transplant but also patients who have chronic GVHD. She also helps run the Long-Term Follow-Up Clinic and recently became SCT Survivorship APP Clinical Director.
References
- Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945-956.
- Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015;21:389-401.e1.
- Bader P, Niethammer D, Willasch A, et al. How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant. 2005;35:107-119.